Immune Potentiators

Immune Potentiators is a class of molecular agents that enhance the magnitude, quality, or durability of immune responses to co-administered antigens by selectively activating or modulating specific innate immune pathways.

21

Publications

1.5K

Citations

146

Authors

38

Institutions

Publications per year

2017–2026

6

Variants

Immunopotentiators

Authors

146

  1. DT
    Derek T. O’Hagan

    Novartis (United States), United States

    3 publications · 307 citations

    3

    h-index

  2. GR
    Gillis R. Otten

    Novartis (United States), United States

    2 publications · 189 citations

    2

    h-index

  3. SR
    Simon R. Hall

    University of Bristol, United Kingdom

    2 publications · 166 citations

    2

    h-index

  4. TW
    Tom Wu

    Genomics Institute of the Novartis Research Foundation, United States

    2 publications · 189 citations

    2

    h-index

  5. HC
    Huaqing Chen

    Wellcome Trust, United Kingdom

    2 publications · 166 citations

    2

    h-index

1–5 of 146

Venues

  1. PubMed

    Repository · 2 publications · 86 citations

    2

    h-index

  2. Molecules

    1 publications · 18 citations

    1

    h-index

  3. Plant Genetic Resources

    1 publications · 121 citations

    1

    h-index

  4. Journal of Pharmaceutical Sciences

    1 publications · 13 citations

    1

    h-index

  5. Nature

    1 publications · 150 citations

    1

    h-index

1–5